Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis CH Wright in vitro and in vivo

被引:96
作者
Gong, Guohua [1 ]
Qin, Yuan [1 ]
Huang, Wen [1 ]
机构
[1] Sichuan Univ, W China Med Sch, W China Hosp, Inst Nanobiomed Technol & Membrane Biol, Chengdu 610041, Peoples R China
关键词
Dioscorea zingiberensis CH Wright; Diosgenin; Anti-thrombosis; Platelet aggregation; Bleeding time; Anticoagulation; ANTITHROMBOTIC ACTIVITY; BLOOD-COAGULATION; BLEEDING-TIME; MODELS; RATS; ANTIPLATELET; AGENTS;
D O I
10.1016/j.phymed.2010.08.015
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Thrombus formation in blood vessel plays an important role in the pathogenesis and progression of atherosclerosis and cardiovascular diseases. Extract of Dioscorea zingiberensis C.H. Wright (D. zingiberensis) is demonstrated to posses activities for curing cardiovascular diseases such as coronary heart disease and angina pectoris. However, there were few studies on anti-thrombosis activity of it. We investigated the anti-thrombosis effect of diosgenin from D. zingiberensis (Dio) in vitro and in vivo on inferior vena cava ligation thrombosis rat model and pulmonary thrombosis mice model. We evaluated the protective effect of Dio by measuring the platelet aggregation, activated partial thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT) and the venous thrombosis in rats and the bleeding time, clotting time and protection rate in mice. Results showed that Dio inhibited platelet aggregation, thrombosis and prolonged APTT, PT and IT in rats in a dose-dependent manner. They also prolonged the bleeding time, clotting time and increased protection rate in mice in a dose-dependent manner. Taken together, these findings suggested that Dio which contained 95% diosgenin had anti-thrombosis activity. Dio executives the anti-thrombosis activity through improving the anticoagulation function, inhibiting platelet aggregation and thrombosis. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 33 条
[1]   Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis [J].
Andriamampandry, MD ;
Leray, C ;
Freund, M ;
Cazenave, JP ;
Gachet, C .
THROMBOSIS RESEARCH, 1999, 93 (01) :9-16
[2]   Anticoagulant activity of marine green and brown algae collected from Jeju Island in Korea [J].
Athukorala, Yasantha ;
Lee, Ki-Wan ;
Kim, Se-Kwon ;
Jeon, You-Jin .
BIORESOURCE TECHNOLOGY, 2007, 98 (09) :1711-1716
[3]   Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart. [J].
Azevedo, Ana Paula S. ;
Farias, Jardel C. ;
Costa, Graciomar C. ;
Ferreira, Susanne C. P. ;
Aragao-Filho, Walmir C. ;
Sousa, Paulo R. A. ;
Pinheiro, Mayara T. ;
Maciel, Marcia C. G. ;
Silva, Lucilene A. ;
Lopes, Adelson S. ;
Barroqueiro, Elizabeth S. B. ;
Borges, Marilene O. R. ;
Guerra, Rosane N. M. ;
Nascimento, Flavia R. F. .
JOURNAL OF ETHNOPHARMACOLOGY, 2007, 111 (01) :155-159
[4]  
BOOS GJ, 2006, FRONT BIOSCI, V11, P328
[5]  
CAYEN MN, 1979, ATHEROSCLEROSIS, V33, P71, DOI 10.1016/0021-9150(79)90199-0
[6]   Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats [J].
Chan, Kung-chi ;
Yin, Mei-chin ;
Chao, Wan-ju .
FOOD AND CHEMICAL TOXICOLOGY, 2007, 45 (03) :502-507
[7]   Pilot treatment of wastewater from Dioscorea zingiberensis CH-Wright production by anaerobic digestion combined with a biological aerated filter [J].
Cheng, Peng ;
Zhao, Huazhang ;
Zhao, Bin ;
Ni, Jinren .
BIORESOURCE TECHNOLOGY, 2009, 100 (12) :2918-2925
[8]  
DIMINNO G, 1983, J PHARMACOL EXP THER, V225, P57
[9]   Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits [J].
Elg, M ;
Carlsson, S ;
Gustafsson, D .
THROMBOSIS RESEARCH, 2001, 101 (03) :159-170
[10]   Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative [J].
Jin, YR ;
Hwang, KA ;
Cho, MR ;
Kim, SY ;
Kim, JH ;
Ryu, CK ;
Son, DJ ;
Park, YH ;
Yun, YP .
VASCULAR PHARMACOLOGY, 2004, 41 (01) :35-41